AI startups are racing into drug development. Here’s 5 burning questions about which will survive. (STAT Plus)

More reads

• AI startups are racing into drug development. Here’s 5 burning questions about which will survive. (STAT Plus)
• Health investment firm OrbiMed growing wary of a tougher FDA. (Bloomberg)
• Biotech execs sign open letter in support of Chinese-American scientists. (Nature)
• Dismal state of Neil Woodford's embattled biotech bets revealed. (Evening Standard)